Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.56 |
| ▸ | FDPS | P14324 | 11/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL412476 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5298378 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL413208 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5301732 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4230960 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5289867 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5294132 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5284441 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL407576 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5294758 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388465-A1 | Production of Diborane | MESSER INDUSTRIES USA, INC. (US) | 2025-12-25 | — | — | US | claimed |
| CN-107835841-B | Crystallization-retarded polymer composition, additive composition influencing crystallization behavior and use, method for reducing crystallization point | 弗劳恩霍弗应用研究促进协会 | 2021-01-05 | — | — | CN | claimed |
| US-10781296-B2 | Polymer composition having delayed crystallization behavior, additive composition that influences the crystallization behavior, method for lowering the crystallization point, and use of an additive composition | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2020-09-22 | — | — | US | claimed |
| CN-111117220-A | Polyamide composition with permanent static dissipation function and application thereof | 会通新材料(上海)有限公司 | 2020-05-08 | — | — | CN | claimed |
| EP-3313938-B1 | POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION | FRAUNHOFER GES FORSCHUNG (DE) | 2019-08-07 | — | — | EP | claimed |
| US-20180186970-A1 | POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2018-07-05 | — | — | US | claimed |
| EP-3313938-A1 | POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION | Fraunhofer Gesellschaft zur Förderung der Angewand (DE) | 2018-05-02 | — | — | EP | claimed |
| WO-2016207003-A1 | POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2016-12-29 | — | — | WO | claimed |
| EP-2440693-B1 | USE OF IONIC FLUIDS FOR PRETREATING PLASTIC SURFACES FOR METALLIZATION | BASF SE (DE) | 2016-08-10 | — | — | EP | claimed |
| US-8993660-B2 | Antistatic thermoplastic compositions | BASF SE (DE) | 2015-03-31 | — | — | US | claimed |
| EP-2242744-B1 | Process for working up ionic liquids | BASF SE (DE) | 2014-06-25 | — | — | EP | claimed |
| EP-2602023-A1 | Catalyst combination for the preparation of polyurethane foams | BASF SE (DE) | 2013-06-12 | — | — | EP | claimed |
| US-20120283367-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2012-11-08 | — | — | US | claimed |
| EP-2509459-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2012-10-17 | — | — | EP | claimed |
| WO-2011069960-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2011-06-16 | — | — | WO | claimed |
| WO-2006077082-A1 | METHOD FOR SEALING ROTATING SHAFTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | WO | claimed |
| EP-4703496-A1 | ETCHING COMPOSITION COMPRISING AT LEAST ONE IONIC LIQUID AND AT LEAST ONE LACTAMIDE AND PROCESS FOR COATING PLASTIC SURFACES WITH METALS BY USING THE SAME | BASF SE (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20250388465-A1 | Production of Diborane | MESSER INDUSTRIES USA, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2006077082-A1 | METHOD FOR SEALING ROTATING SHAFTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | WO | disclosed |
| WO-2005113702-A1 | NOVEL PAIRS OF WORKING SUBSTANCES FOR ABSORPTION HEAT PUMPS, ABSORPTION REFRIGERATION MACHINES AND HEAT TRANSFORMERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388465-A1 | Production of Diborane | HCN4, HCN3, DBF4 | MEN1 3065/4885HSP90AA1 2951/4885KMT2A 1355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.